DS010 not checked

Dartsbio Pharmaceuticals Ltd.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
2 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Once every 3 weeks or once every 4 weeks intravenously injection”In the company’s words, NCT07530666 on ClinicalTrials.gov
Tested for
Cancer (2 trials), Cachexia (2 trials)
Main trialPhase 1/2
“A study to evaluate the safety, tolerability, and preliminary efficacy of DS010 in patients with cancer and cachexia”In the company’s words, NCT07530666 on ClinicalTrials.gov

Other drugs for Cancer

All 2439 drugs for Cancer

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 1/2Not yet recruiting 30 Oct 2027 Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia
Phase 1/2Recruiting 16 Jun 2028 Phase 1/2 Study of DS010 in Advanced Cancer Patients With Cachexia
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow DS010

Following is part of Solo: you see every change to DS010 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in